JEMDOXO MDOXOFYLLINE (SR) 400mg. IP + MONTELUKAST 10mg. IP

Jemdoxo M tablets pair Doxofylline 400 mg with Montelukast 10 mg for prophylaxis and long-term treatment of asthma. Main uses: prophylaxis and long-term treatment of asthma in adults and adolescents; prevention of exercise-induced bronchoconstriction; relief of symptoms of seasonal allergic rhinitis, reserved for patients with an inadequate response or intolerance to alternative therapies because of the risk of serious neuropsychiatric events, including suicidal thoughts or behaviour; relief of symptoms of perennial allergic rhinitis, reserved for patients with an inadequate response or intolerance to alternative therapies because of the risk of serious neuropsychiatric events, including suicidal thoughts or behaviour; helping to keep the airways open in bronchial asthma and other reversible airway obstruction.

Common side effects of Jemdoxo M Tablet include headache; abdominal pain; diarrhoea; nausea or vomiting; palpitations or rapid heartbeat; disturbed sleep or restlessness. Get medical help at once if you notice serious neuropsychiatric events such as agitation, aggression, depression, sleep disturbance and suicidal thoughts or behaviour; severe allergic reactions with swelling of the face, lips or tongue or difficulty in breathing; rash with fever, blisters or peeling of the skin.

Each Jemdoxo M tablet contains Doxofylline (SR) 400 mg + Montelukast 10 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Jemdoxo M Tablet only as your doctor advises.

The MRP of Jemdoxo M Tablet is ₹129 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹98.29 and the PTS is ₹88.46.

Each Jemdoxo M tablet contains Doxofylline (SR) 400 mg + Montelukast 10 mg. It comes in a pack of 10x10 (Alu Alu).

The Montelukast 10 mg part blocks cysteinyl leukotrienes, so airway swelling, mucus and muscle tightening are reduced. Doxofylline 400 mg acts as a bronchodilator, relaxing the smooth muscle of the airways and released steadily from the sustained release tablet. Acting at different points, both ingredients support easier airflow through the day.

Must not be used by anyone with known hypersensitivity to Doxofylline, Montelukast or any other component of the tablet. Must not be used to treat an acute asthma attack; patients should have appropriate rescue medication available. Patients with known aspirin sensitivity should continue to avoid aspirin and other non-steroidal anti-inflammatory medicines while taking this medicine. Check with a doctor first if you have liver or heart disease, a seizure disorder, or a history of mental health problems. Check with a doctor first before stopping or reducing inhaled or oral corticosteroids.

Jemdoxo M Tablet is a brand of Vibcare Pharma, sold through its Auspin division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.